Actively Recruiting
Tolerance Study of Robotic-Assisted Virtual Reality Walking Rehabilitation for Non-Walking Stroke Patients
Led by University Hospital, Limoges · Updated on 2025-01-17
30
Participants Needed
1
Research Sites
94 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The primary objective of this study is to evaluate the tolerance of the use of immersive virtual reality (VR) during robotic walking rehabilitation sessions by Gait Trainer (GT) in post-stroke patients. Secondary objectives aim to evaluate the motivation to participate in VR sessions compared to conventional sessions, the participants' sense of presence within the virtual environment, and the usability of the rehabilitation device created. Finally, we will report the actual walking time and number of steps stroke patients take in VR sessions and conventional sessions.
CONDITIONS
Official Title
Tolerance Study of Robotic-Assisted Virtual Reality Walking Rehabilitation for Non-Walking Stroke Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Hemiparesis following a first ischemic or hemorrhagic stroke
- Stroke in the subacute phase (15 days to 6 months)
- Aged between 35 and 75 years
- Unable to walk 3 times 10 meters without human assistance or Functional Ambulation Classification 2 or less
- Receiving robot-assisted walking rehabilitation in the Physical Medicine and Rehabilitation department of Limoges University Hospital
- Cognitive ability to understand and follow simple verbal instructions (MMSE < 24 or BDAE < 2)
- Able to give informed consent to participate in the study
You will not qualify if you...
- Neurological or psychiatric conditions other than stroke
- Conditions that prevent use of virtual reality (e.g., epilepsy, major cerebellar syndrome)
- Inability to adapt to a virtual environment (MSSQ-Short > 26)
- Acute cardiovascular or respiratory disorders
- Subject to legal protection measures or unable to give consent
- Person deprived of liberty
- High virtual reality experience in the 5 years before stroke
- Pregnant or breastfeeding women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU de Limoges
Limoges, France, 87042
Actively Recruiting
Research Team
M
Maxence COMPAGNAT, MD
CONTACT
C
Charles MORIZIO
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here